3rd Quarter - Report

KEEFE STRATEGIES LLC FKA KEEFE SINGISER PARTNERS for CVS HEALTH

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 19, 2021 $60,000 Replaced
3rd Quarter - Report Oct 20, 2021 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues involving lowering the cost of healthcare and prescription drug prices; quality health care, patient outcomes, health care delivery. Issues related to affordable health insurance coverage during COVID.

LobbyistCovered position, as disclosed
MAURA KEEFE New Chief of Staff, Senator Shaheen -- 2009-2019, Chief of Staff, Rosa DeLauro 1997-2000; press secretary, Rosa DeLauro 1993-1996

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of healthcare, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.

LobbyistCovered position, as disclosed
MAURA KEEFE Chief of Staff, Senator Shaheen -- 2009-2019, Chief of Staff, Rosa DeLauro 1997-2000; press secretary, Rosa DeLauro 1993-1996

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.